Michael A. Kerr

13.3k total citations · 3 hit papers
213 papers, 11.1k citations indexed

About

Michael A. Kerr is a scholar working on Organic Chemistry, Immunology and Molecular Biology. According to data from OpenAlex, Michael A. Kerr has authored 213 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Organic Chemistry, 51 papers in Immunology and 49 papers in Molecular Biology. Recurrent topics in Michael A. Kerr's work include Cyclopropane Reaction Mechanisms (48 papers), Asymmetric Synthesis and Catalysis (42 papers) and Monoclonal and Polyclonal Antibodies Research (37 papers). Michael A. Kerr is often cited by papers focused on Cyclopropane Reaction Mechanisms (48 papers), Asymmetric Synthesis and Catalysis (42 papers) and Monoclonal and Polyclonal Antibodies Research (37 papers). Michael A. Kerr collaborates with scholars based in Canada, United Kingdom and United States. Michael A. Kerr's co-authors include Cheryl A. Carson, Ian S. Young, Jenny M. Woof, Huck K. Grover, Michael R. Emmett, Terry P. Lebold, Avedis Karadeolian, Andrew Leduc, S. Craig Stocks and Paul E. Harrington and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Michael A. Kerr

208 papers receiving 10.8k citations

Hit Papers

Heterocycles from cyclopropanes: applications in natural ... 2005 2026 2012 2019 2009 2005 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Kerr Canada 60 6.7k 1.9k 1.8k 1.2k 471 213 11.1k
Anthony C. Willis Australia 48 5.0k 0.7× 3.1k 1.6× 2.3k 1.3× 409 0.3× 364 0.8× 371 10.9k
Hisashi Yamamoto Japan 38 2.1k 0.3× 1.0k 0.5× 880 0.5× 300 0.3× 449 1.0× 201 5.3k
Beat Ernst Switzerland 42 3.5k 0.5× 4.4k 2.3× 745 0.4× 632 0.5× 103 0.2× 210 7.1k
Akira Otaka Japan 50 2.6k 0.4× 4.6k 2.4× 1.2k 0.7× 581 0.5× 181 0.4× 225 7.9k
Yasuyuki Endo Japan 40 1.4k 0.2× 1.4k 0.7× 481 0.3× 1.7k 1.4× 82 0.2× 299 6.0k
Maurizio Botta Italy 54 5.7k 0.8× 5.5k 2.8× 340 0.2× 180 0.2× 423 0.9× 436 11.9k
Yoshio Hayashi Japan 49 1.9k 0.3× 4.3k 2.2× 1.8k 1.0× 389 0.3× 121 0.3× 379 10.0k
James P. Tam United States 74 3.8k 0.6× 14.8k 7.6× 2.5k 1.4× 2.2k 1.9× 230 0.5× 353 20.5k
James C. Powers United States 54 2.2k 0.3× 5.7k 3.0× 1.5k 0.8× 359 0.3× 899 1.9× 197 10.8k
Carlo Pedone Italy 56 3.8k 0.6× 8.8k 4.5× 439 0.2× 503 0.4× 81 0.2× 401 11.9k

Countries citing papers authored by Michael A. Kerr

Since Specialization
Citations

This map shows the geographic impact of Michael A. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Kerr more than expected).

Fields of papers citing papers by Michael A. Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Kerr. The network helps show where Michael A. Kerr may publish in the future.

Co-authorship network of co-authors of Michael A. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Kerr. A scholar is included among the top collaborators of Michael A. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Kerr. Michael A. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Cerian F, et al.. (2015). Non-pharmacological interventions for people with epilepsy and intellectual disabilities. Cochrane Database of Systematic Reviews. 2015(9). CD005502–CD005502. 11 indexed citations
2.
Kerr, Michael A., et al.. (2009). Domino Synthesis of Bridged Bicyclic Tetrahydro-1,2-oxazines: Access to Stereodefined 4-Aminocyclohexanols. Organic Letters. 11(16). 3694–3697. 73 indexed citations
3.
Thapar, Anita, Michael A. Kerr, & Gordon T. Harold. (2008). Stress, anxiety, depression, and epilepsy: Investigating the relationship between psychological factors and seizures. Epilepsy & Behavior. 14(1). 134–140. 137 indexed citations
4.
Pleass, Richard J., Mark L. Lang, Michael A. Kerr, & Jenny M. Woof. (2006). IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE. Molecular Immunology. 44(6). 1401–1408. 33 indexed citations
5.
Almogren, Ahmad, B. W. Senior, & Michael A. Kerr. (2006). A comparison of the binding of secretory component to immunoglobulin A (IgA) in human colostral S‐IgA1 and S‐IgA2. Immunology. 120(2). 273–280. 24 indexed citations
6.
Carson, Cheryl A. & Michael A. Kerr. (2006). Total Synthesis of (+)‐Phyllantidine. Angewandte Chemie International Edition. 45(39). 6560–6563. 114 indexed citations
7.
Woof, Jenny M. & Michael A. Kerr. (2005). The function of immunoglobulin A in immunity. The Journal of Pathology. 208(2). 270–282. 516 indexed citations breakdown →
8.
Furtado, Patricia B., P. W. Whitty, Alexis Robertson, et al.. (2004). Solution Structure Determination of Monomeric Human IgA2 by X-ray and Neutron Scattering, Analytical Ultracentrifugation and Constrained Modelling: A Comparison with Monomeric Human IgA1. Journal of Molecular Biology. 338(5). 921–941. 87 indexed citations
9.
Bingham, Sarah, Maya H Buch, Michael A. Kerr, Paul Emery, & Anabela Barcelos. (2004). Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide. Arthritis & Rheumatism. 50(12). 4072–4073. 20 indexed citations
10.
Kerr, Michael A.. (2000). Function of immunoglobulin A in immunity. Gut. 47(6). 751–752. 11 indexed citations
11.
Komori, Atsumasa, Sachiko Okabe, Masami Suganuma, et al.. (1996). Anti‐tumor Promoting Activity of Canventol and Its Synthetic Analogs through Inhibition of Protein Isoprenylation. Japanese Journal of Cancer Research. 87(9). 875–881. 3 indexed citations
12.
Stocks, S. Craig, Marie‐Hélène Ruchaud‐Sparagano, Michael A. Kerr, et al.. (1996). CD66: role in the regulation of neutrophil effector function. European Journal of Immunology. 26(12). 2924–2932. 76 indexed citations
13.
Stewart, Wilson W. & Michael A. Kerr. (1995). The Binding of Monomeric IgA to Myeloid FcαR: Evidence for Receptor Re-Cycling and Determination of its Affinity. Advances in experimental medicine and biology. 371A. 655–658. 4 indexed citations
16.
Nicolaou, K. C., et al.. (1993). Design, synthesis and biological activity of protaxols. Nature. 364(6436). 464–466. 104 indexed citations
17.
Stocks, S. Craig & Michael A. Kerr. (1993). Neutrophil NCA-160 (CD66) Is the Major Protein Carrier of Selectin Binding Carbohydrate Groups Lewisx and Sialyl Lewisx. Biochemical and Biophysical Research Communications. 195(1). 478–483. 47 indexed citations
18.
Kerr, Michael A., et al.. (1992). Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates. Molecular Immunology. 29(5). 659–665. 2 indexed citations
19.
Sanders, D. S. A., Diane Milne, & Michael A. Kerr. (1990). The expression of Lewisa and Lewisb antigens reflects changes in fucosylation between normal and neoplastic cervical squamous epithelium. The Journal of Pathology. 162(1). 23–28. 7 indexed citations
20.
Kerr, Michael A.. (1981). [8] Human factor B. Methods in enzymology on CD-ROM/Methods in enzymology. 80 Pt C. 102–112. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026